U2OS-CRISPR-NUP96-mEGFP Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Reporter-labeled cells |
| Organism |
Human |
| Donor History |
Osteosarcoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: McCoys 5a ,w: 3.0 g/L Glucose ,w: stable Glutamine ,w: 2.0 mM Sodium pyruvate ,w: 2.2 g/L NaHCO3 (Cytion article number 820200a). Supplements: Supplement the medium with 10% FBS ,1% NEAA. Dissociation reagent: Accutase. Seeding density: 2 to 3 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The U-2 OS-CRISPR-NUP96-mEGFP is a genetically modified cell line derived from the human osteosarcoma U-2 OS parent line. This cell line incorporates a targeted insertion of the monomeric Enhanced Green Fluorescent Protein (mEGFP) tag at the NUP96 gene locus, achieved through the CRISPR-Cas9 gene-editing technology. NUP96, part of the nuclear pore complex, is essential for nuclear transport, and its fusion with mEGFP allows for real-time visualization of nuclear pore dynamics under fluorescent microscopy, providing valuable insights into nuclear transport mechanisms and nucleocytoplasmic trafficking.
This specific clone, numbered 195, has been selected for its stable expression of the NUP96-mEGFP fusion protein and maintains the typical characteristics of the U-2 OS lineage, including a robust cytoskeletal structure which is critical in studies related to cancer cell migration and metastasis. The application of CRISPR technology ensures precise gene editing, minimizing off-target effects which could compromise the integrity of the experimental outcomes. This makes U-2 OS-CRISPR-NUP96-mEGFP clone no.195 particularly useful for high-resolution imaging techniques and detailed cellular architecture studies, aiding in advanced research in cellular biology, cancer research, and nuclear transport phenomena.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

